D-Glutamate

D-Glutamate

SCHEMBL218574

N[C@@H](CCC(=O)O)C(=O)[O-].N[C@@H](CCC(=O)O)C(=O)[O-].[Mg+2]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of D-Glutamate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.62
GRM8 O00222 1/20 0.62
GRM6 O15303 1/20 0.62
GRIN2D O15399 1/20 0.62
GRIN3B O60391 1/20 0.62
GSR P00390 1/20 0.62
GRIK1 P39086 1/20 0.62
GRM5 P41594 1/20 0.62
GRIA1 P42261 1/20 0.62
GRIA2 P42262 1/20 0.62
GRIA3 P42263 1/20 0.62
SLC1A3 P43003 1/20 0.62
SLC1A2 P43004 1/20 0.62
SLC1A1 P43005 1/20 0.62
GRIA4 P48058 1/20 0.62
GRIN1 Q05586 1/20 0.62
GRIN2A Q12879 1/20 0.62
GRIK2 Q13002 1/20 0.62
GRIK3 Q13003 1/20 0.62
GRIN2B Q13224 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL11697693 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL9241674 0.98 GRM8 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL8987898 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL3499202 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL9646845 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL10824535 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL4025166 0.98 CYP1A2 (0.60) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL718336 0.95 CYP1A2 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL8746869 0.95 CYP1A2 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B
D-Glutamate SCHEMBL1782280 0.95 CYP1A2 (0.62) CYP1A2GRM8GRM6GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122056386-A Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-19 CN claimed
CN-122030612-A Shear-resistant slow-release microcapsule powder and preparation method and application thereof 大连医诺生物股份有限公司 2026-05-15 CN claimed
EP-4710916-A1 COMPOSITION COMPRISING GLUTAMATE FOR CARIES PREVENTION Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) (ES) 2026-03-18 EP claimed
EP-4259092-B1 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2026-02-18 EP claimed
EP-4666864-A1 METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING FOOD AJINOMOTO CO., INC. (JP) 2025-12-24 EP claimed
EP-4666868-A1 METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING LIQUID FOOD AJINOMOTO CO., INC. (JP) 2025-12-24 EP claimed
US-20250366492-A1 METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING FOOD AJINOMOTO CO., INC. (JP) 2025-12-04 US claimed
US-20250366493-A1 METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING LIQUID FOOD AJINOMOTO CO., INC. (JP) 2025-12-04 US claimed
EP-4608985-A1 CELL-FREE PROTEIN SYNTHESIS SYSTEMS, REACTION MIXTURES FOR SAME, AND METHODS FOR PREPARING PROTEINS Sanofi Pasteur Limited (CA) 2025-09-03 EP claimed
CN-119592598-A Application of controllable delivery of substances among multiple membraneless compartments in cell-free system 上海交通大学 2025-03-11 CN claimed
WO-2004004754-A1 NOVEL MEDICAMENT COMBINATIONS BASED ON MAGNESIUM SALTS AND FIBRINOLYTICS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-01-15 WO claimed
US-20030113408-A1 Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage PARSONS, RONALD O. 2003-06-19 US claimed
US-6500450-B1 Composition for treating migraine headaches AKESO HEALTH SCIENCES, LLC 2002-12-31 US claimed
US-6403129-B1 WATER; NONFAT DRY MILK; CALCIUM, MAGNESIUM AND POTASSIUM SALTS; MAC FARMS, INC. 2002-06-11 US claimed
EP-1051086-B1 DIETETIC COMPOSITION IN THE FORM OF A SUBSTITUTION SALT FOR TABLE SALT SANOFI SYNTHELABO (FR) 2002-04-17 EP claimed
US-5851419-A Metal corrosion inhibitive coolant composition containing alkenylsuccinic acid or alkali metal salt thereof CCI CO., LTD. (JP) 1998-12-22 US claimed
EP-0820771-A2 Pharmaceutical compositions for the treatment of neuropathies containing a lipid-soluble thiamine and a magnesium compound WÖRWAG PHARMA GmbH (DE) 1998-01-28 EP claimed
EP-0530220-B1 PHARMACEUTICAL COMPOSITION S & V ENGINEERING KFT (HU) 1997-09-03 EP claimed
EP-0183736-B1 SALT MIXTURE HAVING A LOW SODIUM CONTENT, USED AS SUBSTITUTE FOR COOKING SALT Diamalt GmbH (DE) 1990-07-18 EP claimed
US-4016301-A Electrically conductible gellable composition with ionized salt LECTROFOOD, INC. (US) 1977-04-05 US claimed